Macrophage Migration Inhibitory Factor (MIF) is an important proinflammatory cytokine involved in regulation of macrophage function. In addition, MIF may also play a role in murine and human reproduction. While both first trimester trophoblast and decidua express MIF, the regulation and functional significance of this cytokine during human placental development remains unclear. We assessed MIF expression throughout normal human placental development, as well as in in vitro (chorionic villous explants) and in vivo (high altitude placentae) models of human placental hypoxia. Dimethyloxalylglycine (DMOG), which stabilizes Hypoxia Inducible Factor-1 (HIF-1) under normoxic conditions, was also used to mimic the effects of hypoxia on MIF expression.
INTRODUCTION
Important aspects of placental development are regulated by changes in O 2 tension. During the early stages of pregnancy (prior to 10-12 weeks of gestation), the trophoblast is in a low-oxygen environment due to the absence of maternal blood flow in the intervillous space (36) . With advancing gestation, the maternal circulation becomes fully established and Po 2 increases (22) . Both in vivo and in vitro studies support that the low oxygen environment is required for embryo development and the balance of trophoblast proliferation/differentiation essential for early placental development. Likewise, the late first and second trimester increase in Po 2 is critical to complete the process of trophoblast differentiation/invasion (3, 18 ).
An increasing body of evidence indicates that oxygen tension modifies the expression and activity of a variety of regulatory genes that govern trophoblast differentiation. We have recently shown that oxygen is involved in the modulation of focal adhesion kinase, a key signaling molecule regulating trophoblast proliferation and invasion (28) . In addition we have reported that the early events of trophoblast differentiation are mediated by O 2 -sensitive transcriptional activity of the HIF-1 system and the subsequent expression of TGF-3 (16) . Moreover, in vitro studies demonstrated that low oxygen tension, comparable to that of early placentation, can stimulate the expression of several proinflammatory cytokines, such as Tumor Necrosis Factor-(TNF-) and Interleukin-1 (IL-1) (9) .
MIF is a proinflammatory cytokine first described as a T-cell derived factor capable of inhibiting random migration of macrophages (10, 17) . Although the activity of MIF was originally described in T-lymphocyte-conditioned media, MIF protein and transcript expression has been widely documented in numerous cell types (14, 1) . We focused on MIF in this study because emerging evidence points to MIF as important to early pregnancy development. MIF is expressed during zygote and blastocyst formation in mice (40) . MIF has been detected at the implantation site in maternal decidua, in chorionic villous trophoblast cells and in extravillous trophoblast cells
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within the anchoring villi of humans (5, 6) . However the biological significance of MIF during placental development and in particular its regulation remains to be elucidated.
Because we were struck by the apparent prominence of MIF in early gestational events, we tested the hypothesis that O 2 tension contributes to the regulation of MIF expression and secretion.
Herein we demonstrate that MIF expression is spatially and temporally regulated during placental development. Furthermore we show that low oxygen tension, both environmentally or pharmacologically-induced, increases MIF expression and secretion in an in vitro villous explants system. Finally we demonstrate that MIF expression is elevated in placentae from high altitude pregnancy, an in vivo physiological model of chronic hypoxia.
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MATERIALS AND METHODS
Placental collection and processing
All tissue samples were obtained after informed consent in accordance with participating institutions' Ethics Guidelines. Tissue collection strictly adhered to the guidelines outlined in the Declaration of Helsinki. Placental tissues from first-trimester (5-10 weeks of gestation, n = 19) and second trimester (11-13 weeks of gestation, n = 6; and 14-20 weeks of gestation, n = 7) normal pregnancies, terminated for psychological reasons, were obtained in Toronto, Ontario, Canada by dilatation and curettage. Gestational age was determined by the date of the last menstrual period and ultrasound measurement of crown-rump-length (CRL). High altitude placentae were collected in Leadville, Colorado, USA (HA, 3100 meters above sea level, masl). Moderate altitude placentae were collected in Denver, Colorado, USA (MA, 1600 masl ). Sea level placentae were collected from term deliveries at Mount Sinai Hospital in Toronto, Ontario, Canada (SL, ~40 masl). All third trimester specimens were obtained immediately after delivery from normal looking cotyledons randomly collected. Areas with calcified, necrotic or visually ischemic tissue were omitted from sampling. Subjects suffering from diabetes, essential hypertension and pregnancies affected by preeclampsia and intra uterine growth restriction (IUGR) were excluded. All groups did not show clinical or pathological signs of preeclampsia, infections or other maternal or placental diseases.
Birth weight, gestational age and laboratory values or clinical observations relevant to the health of the mother were abstracted from the clinical records. Term control placental tissues (n=10) were obtained from women with normal pregnancies undergoing elective cesarean section or vaginal delivery at sea level. Samples from high (n=12) and moderate altitude (n=12) were collected from normal pregnancies delivered vaginally or by elective caesarean delivery. The clinical characteristics of the patients are shown in Table 1 . All samples were snap-frozen immediately after collection and stored at -80°C for MIF mRNA and protein analysis or fixed in formalin and embedded in paraffin for immunohistochemistry.
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Villous explant cultures
First trimester placental tissue (5-10 weeks of gestation, 14 separate sets) was obtained from consenting patients undergoing elective termination of pregnancy. Placentae were immediately rinsed in sterile cold phosphate-buffered saline (PBS) and processed within 2 hours of collection.
Endometrial tissue and fetal membranes were dissected out. Terminal villi were then placed on Millicel-CM culture dish inserts (Millipore, Bedford, MA) previously coated with 150N µl of undiluted Matrigel (Collaborative Biomedical Products, Bedford, MA) and transferred to 24-well culture plates. The explants were cultured in DMEM/F12 (GIBCO-BRL, Grand Island, NY) supplemented with 100 µg/ml streptomycin, 100 U/ml penicillin and 2mM glutamine. Explants were maintained in standard condition (5% CO 2 in 95% air, 20% O 2~1 50 mmHg) or in an atmosphere of 3% (92% N 2 and 5% CO 2 ,~21 mmHg ) or 8% (87% N 2 and 5% CO 2, ~57 mmHg) O 2 for 48 hours at 37°C. The morphological integrity and viability of villous explants and their extra villous trophoblast (EVT) outgrowth and migration were monitored daily for the duration of the various experiments as previously reported (16, 32) . In additional experiments we treated explant cultures with dimethyloxalylglycine (DMOG; 1mM; Frontier Scientific, Logan, Utah) for 24 hours under standard oxygenation (20% O 2 ). DMOG is an inhibitor of prolyl-hydroxylases activity mimicking hypoxia via stabilization of HIF-1 (20) . At the end of incubation, supernatants were collected and frozen until assayed for MIF concentration. Explants were either fixed in 4% paraformaldehyde and embedded in paraffin for immunohistochemistry (n=3 separate sets of placental explants, each experimental condition was carried out in triplicate) and in situ hybridization (n=3 separate sets of placental explants) or snap-frozen and processed for protein (n=5 separate sets of placental explants, each experimental condition was carried out in triplicate) and mRNA analysis (n=3 separate sets of placental explants, each experiment condition was carried out in triplicate).
RNA analysis
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Total RNA extracted from placental tissues and villous explants was treated with DNaseI to remove genomic DNA contamination. One µg of total RNA was reverse transcribed using random . Fold change was calculated according to Livak et al (27) .
In situ hybridization
Sections of first trimester villous placental explants cultured at 3% and 20% O 2 were used for MIF mRNA in situ hybridization (ISH). MIF cDNA was generated by oligo-(dT)-primed reverse transcription of T helper cell clones with subsequent amplification using specific oligodeoxyribonucleotide primers (5). After sequencing, an aliquot of the 255 bp PCR product was used to generate (Lig'n Scribe kit, Ambion, TX) the sense and antisense RNA probes tailed with SP6 RNA polymerase promoter without the need for subcloning. Transcription and labelling of RNA probes were performed with 35 S-uridine-5'-(thio)-triphosphate.
Prior to to ISH, 5 µm sections were dewaxed in xylene, taken through a series of graded ethanol, then subjected to enzymatic digestion with pronase (125 µg/ml). Prehybridization, hybridization, removal of nonspecific bound probe by digestion and further washing procedures were performed (33) . Autoradiography was carried out and the slides were developed after exposure for 2 weeks. The specific signal was acquired by a CCD video camera connected to the microscope.
The threshold of specific detection was automatically calibrated on control sections hybridized with the sense probe.
Western blot analysis
Placental tissues and villous explants were homogenized in ice-cold RIPA buffer (Tris-HCl 50 mM, NaCl 150 mM, Triton X100 1% vol/vol, Na deoxycholate 1% wt/vol, SDS 0.1% wt/vol, pH 7.5) supplemented with proteinase inhibitor cocktail (Roche Diagnostic, Mannheim, Germany).
After centrifugation at 15000Xg for 15 minutes at 4°C, the supernatant was assayed for total protein concentration by the Bradford method (12) and MIF was detected by Western blot analysis. Thirty µg of total proteins were separated on 15% polyacrylamide gel in the presence of SDS. Proteins were then transfered to PVDF membranes. Primary anti-human MIF monoclonal antibody (R&D Systems, Abingdon, UK) was used at dilution of 1:500. The membrane was then exposed to horseradish peroxidase conjugated rabbit anti-mouse secondary antibody. The bands were detected using an enhanced chemiluminescence kit (Perkin-Elmer Life Sciences, Boston, MA) according to the manufacturer's instructions. Equal loading of the proteins was confirmed by staining the blots with a 10% (v/v) Ponceau S solution (31) ( Sigma Chemical Co., St. Louis, MO).
Immunohistochemistry
Immunohistochemical analysis was performed using an avidin-biotinylated horseradish peroxidase macromolecular complex (ABC) kit according to the manufacturer's instructions (Vector Laboratories, Burlington, Ontario, Canada). Every 10 th section was stained with hematoxylin and eosin to verify the quality of the tissue, and whether the structures of interest were present within single sections. Selected sections (5 µm) were dewaxed in xylene and rehydrated in a descending alcohol series. Antigen retrieval was carried out by incubating the sections in sodium citrate buffer (10 mM, pH 6) in a microwave oven. Endogenous peroxidase activity was blocked with 3% hydrogen peroxide (vol/vol) in PBS. Slides were then incubated with 5% normal goat serum for 1 hour at room temperature to prevent nonspecific binding. Mouse anti human MIF monoclonal antibody (R&D Systems) was used at 1:200 dilution. After overnight incubation at 4°C with primary antibody, slides were washed several times in PBS and incubated with biotinylated (vol/vol) Tween 20), were added in duplicate (100 µl/well) and incubated for 2 hours at room temperature. The plates were then washed three times and 100 µl of biotinylated goat anti-human MIF antibody (R&D Systems) (200 ng/ml) was added to each well. Plates were incubated for 2 hours at room temperature and then washed again. Streptavidin horseradish peroxidase (Zymed, San Francisco, CA) was subsequently added to each well, after which the plates were incubated for 20 minutes at room temperature. The plates were then washed and 3,3',5,5'-tetramethylbenzidine (Zymed) was added to each well; the reaction was stopped after 20 minutes by adding H 2 SO 4 .
Absorbance was measured at 450 nm using an ELISA SR 400 microplate reader (Sclavo, Siena, Italy). The MIF concentration was extrapolated from a standard curve ranging from 25-2500 pg/ml using human recombinant MIF (R&D Systems) as standard. The sensitivity limit was 18 pg/ml. Intra-and inter-assay coefficients of variation were 3.86 (0.95)% and 9.14 (0.47)%, respectively.
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Data analysis
All data are presented as mean ± SEM of at least 4-6 separate experiments carried out in triplicate. Statistical significance was determined by One Way ANOVA followed by StudentNewman-Keuls post-hoc testing. Significance was defined as p<0.05. qRT-PCR statistical analysis was performed using the relative expression software tool (REST®), a Pair-Wise Fixed Reallocation Randomization Test (34) .
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RESULTS
Expression of MIF during placental development
We first investigated MIF mRNA expression in human placentae throughout gestation by qRT-PCR. Using specific primers and TaqMan probes, we found that MIF transcripts were present at all the examined stages of gestation. However, the pattern of MIF mRNA expression was unique:
it was significantly higher during early pregnancy (7-10 weeks of gestation), then declined in the late first trimester (11-12 weeks of gestation) to levels that remained constant during the second trimester and at term ( Figure 1A) .
A similar expression pattern was obtained at protein level using Western blot analysis. A specific 12 kDa band corresponding to the predicted molecular weight of MIF was expressed throughout gestation. Its intensity was higher in the early first trimester, decreased by week 10 and was similar at all time points tested thereafter ( Figure 1B 
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Effect of oxygen on MIF expression in villous explants
Based on the first set of experiments on the developmental expression of MIF, we hypothesized that changes in oxygen tension might regulate MIF mRNA and protein expression. To test this hypothesis, we cultured chorionic villous explants (5-10 weeks of gestation, 14 separate sets; each experimental condition was repeated 3 times using three different explants from the same placenta) at 3%,(physiological < 10 weeks) (36), 8% (physiological >10 weeks) (22) 
MIF expression in high-altitude placental tissues
To further investigate the effect of low oxygen tension, we performed a quantitative analysis of MIF transcript and protein in normal term placentae from women living at high (3100 masl) moderate (1600 masl) and sea level altitude. MIF mRNA expression increased by 70-fold (p=0.004), and by 26-fold (p=0.001) in high and moderate-altitude vs sea level placentae, respectively ( Figure 4A ). MIF Protein expression was parallel: densitometric analyses revealed a 2-fold increase in MIF at 3100 masl vs. sea level (p<0.05) and a 1.5 fold increase at 1600 masl vs. SL (p <0.05 Figure 4B) . No difference in MIF mRNA and protein expression levels were noted between vaginal delivery and caesarean section (data not shown).
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DISCUSSION
The present findings demonstrate for the first time that MIF expression in human placenta is upregulated by low oxygen tension, both in in vivo and in vitro placenta hypoxia. In this study, we found that MIF mRNA and protein in placental tissues peak at 7-10 weeks of gestation when oxygen is low, while the levels decrease at 11-12 weeks and thereafter when the blood flow is fully established and oxygen tension increases. In vitro experiments confirmed that reduced Po 2 is a powerful inducer of MIF expression from early first trimester trophoblast cells. Explants maintained under low (3%) oxygen tension exhibited significantly higher levels of MIF transcript and protein as well as a higher MIF secretion into conditioned medium with respect to standard (20%) oxygen conditions. Finally we showed that under conditions of chronically reduced oxygen tension in vivo, at the physiological equivalent of 18% inspired O 2 at 1600 m and 15% at 3100 m, MIF expression in placental tissues paralleled that of our in vitro experiments at 8 and 3% O 2 respectively. This remarkable gradation of MIF response in relation to relatively subtle changes in oxygen suggests exquisite sensitivity of MIF regulation to oxygen tension. The present findings are consistent with our recent data showing a pattern of global gene expression that is similar in placentae from first trimester and high altitude pregnancies as well as first trimester villous explants maintained at 3% oxygen (39) . Our results suggest MIF is one of the genes accounting for similarity between in vivo and in vitro models of placental hypoxia.
MIF expression, normally constitutive at low levels, can be induced by increased glucose levels in -cells of the pancreatic islet and adipocytes (46, 37) , mitogens in T-cells (7), corticotrophin-releasing factor (CRF) in the anterior pituitary cells and lipopolysaccharide (LPS) in monocytes-macrophages (45, 15) . More recently, it was shown that human chorionic gonadotrophin (hCG) increases MIF secretion in granulosa cell cultures (44) . Consistent with our experiments testing the influence of HIF-1alpha on MIF expression, new studies on tumor cell lines and cardiac myocytes indicate that MIF is one of the hypoxia-induced genes characterizing tumor phenotypes and that upregulation of MIF mRNA and protein occurs under hypoxic conditions (41, 25, 8) .
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The presence of MIF has been widely demonstrated in tissues and fluids during pregnancy.
MIF transcript and protein are expressed in first trimester trophoblast and evidence of a MIF-like protein was shown in term placenta (5, 49) . MIF is also expressed by term extraembryonic membranes and high concentrations of MIF were detected in amniotic fluid and maternal serum (19) . Although MIF is ubiquitous, increasing or decreasing concentrations of this cytokine have been correlated with various physiological and pathological events during pregnancy. A recent report by Yamada et al. (47) showed decreased MIF plasma levels during early gestation in women with recurrent miscarriages. We previously reported that MIF levels in amniotic fluid are higher at term that in midgestation and higher in laboring than in non laboring women and this is possibly due to the local secretion by fetal membranes (19) . More recently we found that maternal serum MIF is significantly higher in patients affected by severe preeclampsia (42) a clinical condition known to be associated with reduced utero-placental perfusion and placental hypoxia (39) , suggesting that there is increased placental MIF production and secretion into the maternal circulation in response to placental ischemia.
Whether oxygen has a direct effect on MIF induction remains to be elucidated. We have previously reported that in the early phases of placental development, low oxygen tension is associated with increased expression and transcriptional activity of HIF-1 (16), a basic helix-loophelix pre arnt sim (PAS) domain transcription factor. HIF-1 mediates the transcriptional response to oxygen by binding to hypoxia response elements (HRE) in the promoter region of TGF 3, the molecule that mediates the biological effects of low-oxygen environment on the early events of trophoblast differentiation (38) . Interestingly, we found that following treatment of explants with DMOG an inhibitor of HIF-1 degradation (21), high MIF expression levels were preserved also in 20% of oxygen. Moreover, using in silico analysis we have recently identified three putative binding sites for HIF-1 in the promoter region of the human MIF gene (data not shown). Such data suggest that the HIF system is responsible for the graded MIF response to changes in oxygen tension.
Page 15 of 32
The specific role of MIF during placentation remains unclear. MIF is an important regulator of cell proliferation and differentiation (48, 26) . Normal placental development is dependent upon proliferation of the cytotrophoblast and further differentiation of the various trophoblast cell populations: the syncytiotrophoblast which forms the epithelial covering of the villous tree and is the main endocrine component of the placenta, the villous cytotrophoblast which represents the trophoblast stem cell population that proliferates throughout pregnancy and fuses to generate the syncytiotrophoblast layer, and the extravillous trophoblast cells which anchor the villi to the maternal uterus. It is well established that during early placental development low oxygen environment supports the early events of trophoblast differentiation including proliferation of the undifferentiated villous cytotrophoblast (18, 16) and of the extravillous trophoblast cells forming the proximal column of the anchoring villi (16) . Higher MIF expression in the early stages of placentation and its localization to the villous cytotrophoblast suggests that MIF might contribute to sustain the trophoblast proliferative phenotype, typical of low oxygen environment. Consistent with our previous reports (5), we showed that immunostaining for MIF in the proliferative villous cytotrophoblast and extravillous trophoblast was drastically reduced by the 13th week of gestation.
First trimester explants also showed MIF protein and transcript expression in the proliferative cytotrophoblast and in the extravillous trophoblast with prominent staining in the cellular outgrowth of cultures maintained in 3% O 2 . Intranuclear MIF immunoreactivity observed in trophoblast cells, particularly in 3% O 2 explants, seems to be in agreement with reports on other cell types possessing a high proliferation index, e.g. pituitary adenoma and lung adenocarcinoma cells (35, 23) . The proliferative response to MIF stimulation in fibroblasts is associated with phosphorylation and activation of p44/p42 ERK (extracellular signal-regulated kinase 1/2) (30). In human placenta, the expression of ERK1 and ERK2 is localized in the proliferative cytotrophoblast and, interestingly, expression of active forms of ERK1/ERK2 is much higher in first trimester placental tissues compared to second trimester (24) . The primary action of MIF is on macrophages, where it inhibits their migration and stimulates their scavenger activity at the site of inflammation (10) . Macrophages constitute the majority of immune cell types populating the endometrium and decidua, and their number increases during early pregnancy (29) . Decidual macrophages help to remove cellular debris, thereby facilitating the invasion of trophoblast into the maternal tissues (2) . We showed that in vitro explants release high levels of MIF under reduced oxygenation. Hence MIF could be a paracrine mediator in early gestation, determining macrophage accumulation and activation.
Alternatively, MIF could also suppress activity of decidual NK cells, an important population in the maternal decidua, particularly at the implantation site (43) . Indeed, MIF inhibits NK cell-mediated cytolysis of both neoplastic and normal target cells (4) . Although the functions of decidual NK cells must be clarified, inhibition of their cytolytic activity could be a critical mechanism of immunotolerance at the feto-maternal interface.
Although these studies support a central role of MIF in human pregnancy, MIF -/-mice failed to show reduced fertility (11) . However from the relevant report, litter sizes, pup weight and other indicators of functional pregnancy outcome were not examined (11) . Additionally, MIF has complex interactions with other cytokines, i.e. TNF-, IFN-and IL-1 (13) . Hence, it can be hypothesized that other cytokines compensate for the deficiency of MIF. 
